Taurolidine-containing solution for reducing cardiac implantable electronic device infection-early report from the European TauroPace™ registry

Taurolidine-containing solution for reducing cardiac implantable electronic device infection-early report from the European TauroPace™ registry

Abstract Introduction Infection is a significant complication of cardiac implantable electronic device (CIED) therapy. The European TauroPace™ Registry investigates the safety and efficacy of TauroPace™ (TP), an antimicrobial solution containing taurolidine, designed to prevent CIED infections. Meth...

Full description

Bibliographic Details
Main Authors: Reinhard Vonthein, Benito Baldauf, Stefan Borov, Ernest W. Lau, Marzia Giaccardi, Ojan Assadian, Christelle Haddad, Philippe Chévalier, Kerstin Bode, Paul Foley, Honey Thomas, Niall G. Campbell, Stephanie Fichtner, Luca Donazzan, Felix Pescoller, Rainer Oberhollenzer, Roberto Cemin, Hendrik Bonnemeier
Format: Article
Language:English
Published: BMC 2024-10-01
Series:Journal of Cardiothoracic Surgery
Subjects:
Surgical site infection
Antimicrobial compound
Permanent pacemaker
Subcutaneous implantable cardioverter defibrillator
Cardiac resynchronization therapy
Cardiac contractility modulation
Online Access:https://doi.org/10.1186/s13019-024-03059-1

Internet

https://doi.org/10.1186/s13019-024-03059-1

Similar Items